相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization
Antonina Germano et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Nelson's syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies
Jimmy Patel et al.
NEUROSURGICAL FOCUS (2015)
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study
Rosario Pivonello et al.
CLINICAL ENDOCRINOLOGY (2014)
Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
Astrid Breitschaft et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease
Andrea Osswald et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Outcomes of Proton Therapy for Patients With Functional Pituitary Adenomas
Daniel A. Wattson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
ARMC5 Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia
Guilherme Asmar Alencar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Changes in Plasma ACTH Levels and Corticotroph Tumor Size in Patients With Cushing's Disease During Long-term Treatment With the Glucocorticoid Receptor Antagonist Mifepristone
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Ketoconazole in Cushing's Disease: Is It Worth a Try?
Frederic Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
Ciara O'Sullivan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
Xavier Bertagna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines
Antonina Germano et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Genetics and epigenetics of adrenocortical tumors
Antonio M. Lerario et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM): A Case Series
Brad E. Zacharia et al.
NEUROSURGERY (2014)
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
M. Barbot et al.
PITUITARY (2014)
The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial (vol 5, pg 232, 2014)
Antonio M. Lerario et al.
HORMONES & CANCER (2014)
Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells
Segolene Hescot et al.
ENDOCRINE-RELATED CANCER (2013)
Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane
Peter M. t van Koetsveld et al.
ENDOCRINE-RELATED CANCER (2013)
Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study
Krystallenia I. Alexandraki et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Sustained Improvements in Plasma ACTH and Clinical Status in a Patient With Nelson's Syndrome Treated With Pasireotide LAR, a Multireceptor Somatostatin Analog
Laurence Katznelson
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
R. van der Pas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study
Olaf M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
Robert R. Henry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome
Guillaume Assie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Intraadrenal Corticotropin in Bilateral Macronodular Adrenal Hyperplasia
Estelle Louiset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cabergoline Therapy for Cushing Disease Throughout Pregnancy
Irene Woo et al.
OBSTETRICS AND GYNECOLOGY (2013)
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase
Johannes Hofland et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up
Pablo Valderrábano et al.
Endocrinologia y Nutricion (2013)
Subclinical Cushing's syndrome
Monica De Leo et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer
Marco Volante et al.
CLINICAL CANCER RESEARCH (2012)
Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study
Victoria Delgado et al.
CLINICAL ENDOCRINOLOGY (2012)
A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome
Elena Valassi et al.
CLINICAL ENDOCRINOLOGY (2012)
New developments in the medical treatment of Cushing's syndrome
R. van der Pas et al.
ENDOCRINE-RELATED CANCER (2012)
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Camille Baudry et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion
S. T. Sharma et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
The burden of Cushing's disease: clinical and health-related quality of life aspects
R. A. Feelders et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion
C. de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years
Zaki K. Hassan-Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Potential Role for Retinoic Acid in Patients with Cushing's Disease
Francesca Pecori Giraldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effects of somatostatin analogs on glucose homeostasis in rats
Herbert A. Schmid et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Fluconazole inhibits human adrenocortical steroidogenesis in vitro
R. van der Pas et al.
JOURNAL OF ENDOCRINOLOGY (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome
Frederic Castinetti et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2012)
Effects of mitotane treatment on human steroid metabolism: implications for patient management
L. Ghataore et al.
ENDOCRINE CONNECTIONS (2012)
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
Matthias Kroiss et al.
CLINICAL ENDOCRINOLOGY (2011)
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Ann I. McCormack et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
Peter Kamenicky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study
D. J. F. Stuijver et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature
R. N. Clayton et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Adrenocortical carcinoma: a clinician's update
Martin Fassnacht et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Management of Cushing disease
Nicholas A. Tritos et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Troy H. Dillard et al.
PITUITARY (2011)
Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone
Phillip J. Monaghan et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
CT Findings of Primary Pigmented Nodular Adrenocortical Disease: Rare Cause of ACTH-Independent Cushing Syndrome
Nikos Courcoutsakis et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Ariane Godbout et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
H. Bode et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers
Martin Fassnacht et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Neuropsychiatric Disorders in Cushing's Syndrome
Alberto M. Pereira et al.
NEUROENDOCRINOLOGY (2010)
Genetics of Cushing's Syndrome
Maria Yaneva et al.
NEUROENDOCRINOLOGY (2010)
Medical Treatment of Cushing's Syndrome: Adrenal-Blocking Drugs and Ketaconazole
Richard A. Feelders et al.
NEUROENDOCRINOLOGY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Lucio Vilar et al.
PITUITARY (2010)
Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease - Report of a Case and Literature Review
Lorenzo Curto et al.
THESCIENTIFICWORLDJOURNAL (2010)
Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review
Robert M. Starke et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
ACTH-independent macronodular adrenal hyperplasia
Andre Lacroix
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Rationale for treatment and therapeutic options in Cushing's disease
Paul M. Stewart et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Clinical management of adrenocortical carcinoma
Martin Fassnacht et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD)
M. A. E. M. Wagenmakers et al.
CLINICAL ENDOCRINOLOGY (2009)
Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Drugs in the medical treatment of Cushing's syndrome
David E. Schteingart
EXPERT OPINION ON EMERGING DRUGS (2009)
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
Christiaan de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Management of Endocrine Manifestations and the Use of Mitotane As a Chemotherapeutic Agent for Adrenocortical Carcinoma
Irina Veytsman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bilateral Adrenalectomy for Refractory Cushing Disease: A Safe and Definitive Therapy
Philip W. Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS: CASE REPORT
Safraz Mohammed et al.
NEUROSURGERY (2009)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement
B. M. K. Biller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas
Joshua H. Petit et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Adjuvant mitotane treatment for adrenocortical carcinoma
Massimo Terzolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adrenal cortical carcinoma - Review of current knowledge and treatment practices
Alexandria T. Phan
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Dopamine agonists and the risk of cardiac-valve regurgitation
Rene Schade et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dopamine receptor expression and function in corticotroph ectopic tumors
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans
Nancy Nader et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long term control of hypercortisolism with fluconazole:: case report and in vitro studies
M Riedl et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission
JR Lindsay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long-term follow-up
AM Isidori et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance
AB Atkinson et al.
CLINICAL ENDOCRINOLOGY (2005)
Cushing's syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health
I Ilias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Cabergoline plus lanreotide for ectopic Cushing's syndrome
R Pivonello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma
RJ Benveniste et al.
JOURNAL OF NEUROSURGERY (2005)
Differential diagnosis and imaging in Cushing's syndrome
JR Lindsay et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission
DA Rees et al.
CLINICAL ENDOCRINOLOGY (2002)
Adrenocortical carcinoma: Clinical, morphologic, and molecular characterization
A Stojadinovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Retinoic acid prevents experimental Cushing syndrome
M Páez-Pereda et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion
JP Aniszewski et al.
WORLD JOURNAL OF SURGERY (2001)
分享论文
